Authors
Loading...
Expert workshop review reveals how precursor sequences, tissue microenvironments, and proteostatic capacity govern amyloid organ targeting, highlighting novel therapeutic avenues.
Giampaolo Merlini (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: